Back to search

Article

Efficacy and Safety of Artemether-Lumefantrine and Dihydroartemisinin-Piperaquine for The Treatment of Uncomplicated Plasmodium Falciparum Malaria and Prevalence of Molecular Markers Associated With Artemisinin and Partner Drug Resistance in Uganda

2021-07-24

Abstract excerpt

<h4>Background: </h4> In Uganda, artemether-lumefantrine (AL) is the first-line therapy and dihydroartemisinin-piperaquine (DP) the second-line therapy for the treatment of uncomplicated malaria. We evaluated the efficacy and safety of AL and DP in the management of uncomplicated Plasmodium falciparum malaria and measured the prevalence of molecular markers of resistance in three sentinel sites from 2018–2019 in U...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
8f40ab4f-39e3-5d7a-ad29-24be91993b91
DOI
10.21203/rs.3.rs-738188/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Efficacy and Safety of Artemether-Lumefantrine and Dihydroartemisinin-Piperaquine for The Treatment of Uncomplicated Plasmodium Falciparum Malaria and Prevalence of Molecular Markers Associated With Artemisinin and Partner Drug Resistance in UgandaDOI 10.21203/rs.3.rs-738188/v1
Changes in susceptibility of Plasmodium falciparum to antimalarial drugs in Uganda over time: 2019-2024.Semantic proximity
Comparative impacts over 5 years of artemisinin-based combination therapies on Plasmodium falciparum polymorphisms that modulate drug sensitivity in Ugandan children.Semantic proximity
Sustained High Prevalence of Multiple Antimalarial Drug Resistance Markers in Uganda in 2023-24Semantic proximity
Clinical efficacy of artemisinin-lumefantrine and status of antifolate drug resistance markers in western KenyaSemantic proximity
Sustained high prevalence of multiple antimalarial drug resistance markers in Uganda in 2023-2024.Semantic proximity
Evidence of artemisinin partial resistance in North-western Tanzania: clinical and drug resistance markers studySemantic proximity
Artemisinin and partner drug resistance markers in Plasmodium falciparum from Tanzanian paediatric malaria patients, 2016–2022Semantic proximity
A retrospective analysis of P. falciparum drug resistance markers detects an early (2016/17) high prevalence of the k13 C469Y mutation in asymptomatic infections in Northern Uganda.Semantic proximity
Emerging threat of Partial Artemisinin Resistance Markers in P. falciparum Parasite Populations in multiple geographical locations in high Transmission Regions of UgandaSemantic proximity
Changing Antimalarial Drug Resistance Patterns Identified by Surveillance at Three Sites in Uganda.Semantic proximity
Changes in susceptibility of <i>Plasmodium falciparum</i> to antimalarial drugs in Uganda over time: 2019-2024Semantic proximity
Therapeutic efficacy of artemether–lumefantrine in North-Eastern states of India and prevalence of drug resistance-associated molecular markersSemantic proximity
Select a neighboring publication to make it the new centre.